Healthtech Series A Investors & VC Firms
2309 firms in this list, with a median first check of $500K. 550 of them lead rounds. Generated from verified public data and updated continuously.
Recode Ventures
San FranciscoSeed–Series A
8 people
Relia Health
OntarioPre-Seed–Series A
5 people
TruVenturo GmbH
HamburgSeed–Series A
8 people
Netrove
Kuala LumpurPre-Seed–Growth$50K – $500K
2 people
Sound Media Ventures
AtlantaSeed–Series A
2 people
What If Ventures
FriscoPre-Seed–Late Stage
3 people
Lang Sheng Investment Group Co. Ltd.
ShanghaiPre-Seed–Series A
7 people
WXR Fund
San FranciscoSeed–Series A$100K – $1M
4 people
Chile Ventures
SantiagoSeed–Series A$50K – $1M
2 people
Belle Impact Fund
Grosse Pointe FarmsSeed–Series A$25K – $250K
3 people
Consorcio Ventures
SantiagoSeed–Series A$500K – $2.5M
6 people
Cradle Seed Ventures
Kuala LumpurSeed–Growth$225K – $675K
3 people
Utiliti Group
SydneySeed–Growth
Rogue Capital
San FranciscoPre-Seed–Series A
1 person
CloudStone Capital
San MateoSeed–Series A
5 people
Curitas Ventures
StockholmSeed–Growth
5 people
FRC FUND MANAGEMENT S.À R.L.
ZagrebPre-Seed–Series A
11 people
Northwestern Medicine Innovation, LLC
ChicagoSeed–Series A
11 people
Vesalius Biocapital Partners
LuxembourgSeed–Growth$11M
5 people
ASICS Ventures Corporation
KobePre-Seed–Growth$100K – $5M
2 people
Beaconsfield Capital
Seed–Series B
2 people
Cobalt Ventures
Kansas CitySeries A–Series B$10M – $75M
2 people
Tetrad
NicosiaPre-Seed–Series A$100K – $1M
2 people
Attack Capital
BrooklynPre-Seed–Series A$150K
4 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Healthtech Investors & VC Firms (4190)Series A Investors & VC Firms in United States (3838)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2665)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Healthtech Investors & VC Firms in United States (2436)Series A Investors & VC Firms in Europe (2383)
Data sourced from public filings and firms' own websites — see our methodology.



































































